LeonaBio, Inc. (LONA)
6.14
+0.39
(+6.78%)
USD |
NASDAQ |
Oct 12, 16:00
6.14
0.00 (0.00%)
After-Hours: 16:16
LeonaBio Net Income (Quarterly) : -19.01M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.01M |
| March 31, 2026 | -32.95M |
| December 31, 2025 | -82.89M |
| September 30, 2025 | -6.611M |
| June 30, 2025 | -6.966M |
| March 31, 2025 | -9.143M |
| December 31, 2024 | -15.00M |
| September 30, 2024 | -28.74M |
| June 30, 2024 | -26.86M |
| March 31, 2024 | -26.34M |
| December 31, 2023 | -27.28M |
| September 30, 2023 | -32.97M |
| June 30, 2023 | -29.60M |
| March 31, 2023 | -27.82M |
| Date | Value |
|---|---|
| December 31, 2022 | -30.14M |
| September 30, 2022 | -20.19M |
| June 30, 2022 | -24.34M |
| March 31, 2022 | -20.98M |
| December 31, 2021 | -16.34M |
| September 30, 2021 | -15.67M |
| June 30, 2021 | -13.97M |
| March 31, 2021 | -8.866M |
| December 31, 2020 | -7.702M |
| September 30, 2020 | -8.456M |
| June 30, 2020 | -1.992M |
| March 31, 2020 | -1.805M |
| December 31, 2019 | -0.974M |
| September 30, 2019 | -1.53M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 19.01M |
| EPS Diluted (Quarterly) | -0.8011 |
| Enterprise Value | 3.685M |
| Earnings Yield | -376.4% |
| Normalized Earnings Yield | -178.18 |